Ghana Pharmaceutical Manufacturing Policy

Also known as: GPMP

2026-10-282026-10-31

News reports

Order a long-term news report on Ghana Pharmaceutical Manufacturing Policy

Every mention in the Ghanaian press over the period you choose, compiled as a PDF or Word document.

In coverage

Verbatim sentences from the source article.

October 2026
29 OctJoy Online
The government has launched the Cabinet-approved Ghana Pharmaceutical Manufacturing Policy, seeking to double domestic medicine production, create skilled jobs and position the country as a leading pharmaceutical manufacturing hub in West Africa. …
Trade Ministry launches pharmaceutical policy to double local medicine production
29 OctJoy Online
… Speaking at the launch of the Ghana Pharmaceutical Manufacturing Policy (GPMP) at the Ghana EXIM Bank premises, Dr Sodzi-Tettey said the policy would address critical questions that have long hindered financing for local manufacturers. …
Ghana’s pharmaceutical industry has entered its ‘golden era’ – NVI CEO
29 OctJoy Online
… Speaking at the launch of the Ghana Pharmaceutical Manufacturing Policy (GPMP) at the Ghana EXIM Bank premises on Wednesday, Dr Sodzi-Tettey said the laboratory, set to be launched by President John Dramani Mahama this year, positions Ghana at the forefront of next-generation vac …
NVI’s mRNA Lab: Vaccine Institute CEO celebrates Ghana’s leap into next-generation vaccine technology
28 OctJoy Online
… Speaking at the launch of the Ghana Pharmaceutical Manufacturing Policy on Wednesday, October 28, Dr. …
Ghana targets reduced medicine imports under new pharmaceutical policy

Business

Ghana launches policy to double local pharmaceutical manufacturing

The News

The government has launched the Cabinet-approved Ghana Pharmaceutical Manufacturing Policy to double domestic medicine production, address dependence on imports (which account for 70% of medicine supply), and increase locally manufactured medicines' share of the domestic market from 30% to 60%. The policy, announced by the Trade Minister, provides a coordinated framework covering investment, regulation, public procurement, skills development, and regional trade.

29 October 2026 · Joy Online →

Thursday 29 October

Ghana launches policy to double local pharmaceutical manufacturing
The government has launched the Cabinet-approved Ghana Pharmaceutical Manufacturing Policy to double domestic medicine production, address dependence on imports (which account for 70% of medicine supply), and increase locally manufactured medicines' share of the domestic market from 30% to 60%. The policy, announced by the Trade Minister, provides a coordinated framework covering investment, regulation, public procurement, skills development, and regional trade.
29 October 2026 · Joy Online →
Ghana launches pharmaceutical policy to advance vaccine manufacturing
Ghana's National Vaccine Institute CEO declared the pharmaceutical industry has entered a "golden era" as the government launched the Ghana Pharmaceutical Manufacturing Policy on October 28, 2026, aimed at transforming Ghana into a continental hub for medicine and vaccine manufacturing. The policy addresses financing challenges facing local manufacturers, including support for private manufacturers Atlantic Lifesciences and DEK Vaccines Ltd, which require at least $100 million to build and equip their plants.
29 October 2026 · Joy Online →
Ghana joins five African nations with mRNA vaccine laboratory
The National Vaccine Institute has established a state-of-the-art mRNA laboratory at the Noguchi Memorial Institute for Medical Research, making Ghana one of only five African countries with this technology. The facility, to be launched by President Mahama this year, positions Ghana to develop and manufacture vaccines locally rather than relying on imports.
29 October 2026 · Joy Online →

Wednesday 28 October

Ghana launches pharmaceutical policy to boost local medicine production
Ghana's Presidential Coordinator for the Pharmaceutical Hub announced the Cabinet-approved Pharmaceutical Manufacturing Policy, which aims to increase domestic medicine production and reduce import dependence by addressing challenges in finance, infrastructure, raw materials, skills, and investment incentives.
28 October 2026 · Joy Online →